Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $120.60 million. The enterprise value is $186.22 million.
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 96.48 million shares outstanding. The number of shares has increased by 24.31% in one year.
| Current Share Class | 96.48M |
| Shares Outstanding | 96.48M |
| Shares Change (YoY) | +24.31% |
| Shares Change (QoQ) | +5.30% |
| Owned by Insiders (%) | 7.32% |
| Owned by Institutions (%) | 23.76% |
| Float | 40.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.75 |
| Forward PS | 0.70 |
| PB Ratio | 5.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 3.92.
| Current Ratio | 2.01 |
| Quick Ratio | 1.37 |
| Debt / Equity | 3.92 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.65 |
Financial Efficiency
Return on equity (ROE) is -85.58% and return on invested capital (ROIC) is -7.86%.
| Return on Equity (ROE) | -85.58% |
| Return on Assets (ROA) | -16.64% |
| Return on Invested Capital (ROIC) | -7.86% |
| Return on Capital Employed (ROCE) | -13.89% |
| Weighted Average Cost of Capital (WACC) | 10.02% |
| Revenue Per Employee | $242,798 |
| Profits Per Employee | -$35,074 |
| Employee Count | 658 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 16.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.11% in the last 52 weeks. The beta is 1.32, so Neuronetics's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -16.11% |
| 50-Day Moving Average | 2.18 |
| 200-Day Moving Average | 1.86 |
| Relative Strength Index (RSI) | 30.29 |
| Average Volume (20 Days) | 3,450,564 |
Short Selling Information
The latest short interest is 6.66 million, so 6.90% of the outstanding shares have been sold short.
| Short Interest | 6.66M |
| Short Previous Month | 7.21M |
| Short % of Shares Out | 6.90% |
| Short % of Float | 16.51% |
| Short Ratio (days to cover) | 9.24 |
Income Statement
In the last 12 months, Neuronetics had revenue of $159.76 million and -$23.08 million in losses. Loss per share was -$0.32.
| Revenue | 159.76M |
| Gross Profit | 81.37M |
| Operating Income | -14.60M |
| Pretax Income | -23.01M |
| Net Income | -23.08M |
| EBITDA | -11.68M |
| EBIT | -14.60M |
| Loss Per Share | -$0.32 |
Full Income Statement Balance Sheet
The company has $22.11 million in cash and $87.73 million in debt, with a net cash position of -$65.62 million or -$0.68 per share.
| Cash & Cash Equivalents | 22.11M |
| Total Debt | 87.73M |
| Net Cash | -65.62M |
| Net Cash Per Share | -$0.68 |
| Equity (Book Value) | 22.40M |
| Book Value Per Share | 0.24 |
| Working Capital | 27.03M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.28 million and capital expenditures -$1.30 million, giving a free cash flow of -$9.58 million.
| Operating Cash Flow | -8.28M |
| Capital Expenditures | -1.30M |
| Depreciation & Amortization | 2.92M |
| Net Borrowing | -5.63M |
| Free Cash Flow | -9.58M |
| FCF Per Share | -$0.10 |
Full Cash Flow Statement Margins
Gross margin is 50.93%, with operating and profit margins of -9.14% and -14.45%.
| Gross Margin | 50.93% |
| Operating Margin | -9.14% |
| Pretax Margin | -14.40% |
| Profit Margin | -14.45% |
| EBITDA Margin | -7.31% |
| EBIT Margin | -9.14% |
| FCF Margin | n/a |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -24.31% |
| Shareholder Yield | -24.31% |
| Earnings Yield | -25.59% |
| FCF Yield | -7.95% |
Analyst Forecast
The average price target for Neuronetics is $6.00, which is 380.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 380.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 9.03% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -3.21 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.21 |
| Piotroski F-Score | 3 |